Literature DB >> 33786232

Chronic Pelvic Pain Syndrome in a Rural Area: Are We Paying Attention?

Omar S Akhtar1,2.   

Abstract

Introduction Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a chronic, debilitating illness that mostly affects males under the age of 50 years. It is associated with myriad presentations. The National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) score was developed to measure the impact of the disease and assess the treatment outcomes. Additionally, the UPOINT [urinary (U), psychosocial (P), organ-specific (O), infection (I), neurologic/systemic (N), and tenderness of pelvic floor skeletal muscles (T)] classification system has been developed to enable a 'phenotypic approach' to the treatment. Objective The objective of this study was to determine the NIH-CPSI scores as well as the positive subdomain numbers and distribution of the UPOINT classification in patients with CP/CPPS. Materials and methods A total of 100 consecutive male patients presenting to a single centre with symptomatic CP/CPPS were included in this study. Results The mean age of the patients was 34.4 years. The average total NIH-CPSI score was 24.9. The average number of positive UPOINT domains was 2.28. The positive domains were urinary (90), psychosocial (60), organ-specific (43), infection (15), neurological (12), and tenderness (8). Discussion The NIH-CPSI scores and UPOINT subdomain scores compared favourably with other studies conducted in the region. The lower infection subdomain score as compared to other studies may be due to the widespread use of antibiotics among patients in the region prior to presenting to a urologist. Conclusion The use of the UPOINT classification to guide treatment is feasible even in a rural setting, such as in Kashmir.
Copyright © 2021, Akhtar et al.

Entities:  

Keywords:  chronic pelvic pain syndrome; chronic prostatitis; lower urinary tract synptoms; prostatitis

Year:  2021        PMID: 33786232      PMCID: PMC7994930          DOI: 10.7759/cureus.13525

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

1.  Prostatitis.

Authors:  J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

2.  Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.

Authors:  Daniel A Shoskes; J Curtis Nickel; Michael W Kattan
Journal:  Urology       Date:  2010-04-03       Impact factor: 2.649

3.  Multidisciplinary approach to prostatitis.

Authors:  Vittorio Magri; Matteo Boltri; Tommaso Cai; Roberto Colombo; Salvatore Cuzzocrea; Pieter De Visschere; Rosanna Giuberti; Clara Maria Granatieri; Maria Agnese Latino; Gaetano Larganà; Christian Leli; Giorgio Maierna; Valentina Marchese; Elisabetta Massa; Alberto Matteelli; Emanuele Montanari; Giuseppe Morgia; Kurt G Naber; Vaia Papadouli; Gianpaolo Perletti; Nektaria Rekleiti; Giorgio I Russo; Alessandra Sensini; Konstantinos Stamatiou; Alberto Trinchieri; Florian M E Wagenlehner
Journal:  Arch Ital Urol Androl       Date:  2019-01-18

4.  A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study.

Authors:  Kathleen Joy Propert; Mary McNaughton-Collins; Benjamin E Leiby; Michael P O'Leary; John W Kusek; Mark S Litwin
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

5.  Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network.

Authors:  M McNaughton Collins; M A Pontari; M P O'Leary; E A Calhoun; J Santanna; J R Landis; J W Kusek; M S Litwin
Journal:  J Gen Intern Med       Date:  2001-10       Impact factor: 5.128

6.  Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.

Authors:  Aare Mehik; Peeter Alas; J Curtis Nickel; Ari Sarpola; Pekka J Helström
Journal:  Urology       Date:  2003-09       Impact factor: 2.649

7.  Mechanisms in prostatitis/chronic pelvic pain syndrome.

Authors:  Michel A Pontari; Michael R Ruggieri
Journal:  J Urol       Date:  2008-05       Impact factor: 7.450

8.  Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity.

Authors:  Daniel A Shoskes; J Curtis Nickel; Robert Dolinga; Donna Prots
Journal:  Urology       Date:  2009-01-01       Impact factor: 2.649

9.  A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.

Authors:  Florian M E Wagenlehner; Henning Schneider; Martin Ludwig; Jörg Schnitker; Elmar Brähler; Wolfgang Weidner
Journal:  Eur Urol       Date:  2009-06-03       Impact factor: 20.096

10.  Use of the UPOINT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study.

Authors:  Xiao Guan; Cheng Zhao; Zhen-Yu Ou; Long Wang; Feng Zeng; Lin Qi; Zheng-Yan Tang; Jin-Geng Dun; Long-Fei Liu
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.